Please assess the completion status of the following clinical trial:

Trial Title: To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male of female aged 20 years or more~* History of reflux esophagitis~* Ongoing (until date of Visit 1) treatment with rabeprazole 10 mg, given once daily, for at least 4 weeks.The subject must take rabeprazole at least 4 days a week in the past 7 days prior to Visit 1.~* Persisting symptoms of heartburn experienced at least 2 days during the past 7 days prior to Visit 1.~Exclusion Criteria:~* Use of other PPIs and/or H2RA during rabeprazole treatment~* History or having other gastrointestinal diseases~* History of upper gastrointestinal surgery~* Initiation of medications that can affect digestive functions within 4 weeks before study treatment~* Inability to complete questionnaires

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- esomeprazole 20 mg (Type: OTHER): esomeprazole 20 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).